Interviews from the EAU 2012
Interviews of Prof Mark Emberton and Dr Jan de Boer after their presentations at the EAU 2012 in Paris. They have unique insights about BPH and how to… read more.
Interviews of Prof Mark Emberton and Dr Jan de Boer after their presentations at the EAU 2012 in Paris. They have unique insights about BPH and how to… read more.
by Bruce Sylvester – Emerging uses of FDA Approved Drugs – Botulinum toxin treatment appears to improve tremor in the arms and hands of persons with multiple sclerosis… read more.
Men with prostate cancer in Texas may be driving more than three times farther than needed to obtain radiation oncology treatments for their cancer when treated at a… read more.
Emerging uses of FDA Approved Drugs – by Bruce Sylvester – Results from the largest study yet of the treatment of urinary incontinence with botulinum toxin suggests that… read more.
The difficulties that many women describe as memory problems when menopause approaches are real, according to a study published today in the journal Menopause, the journal of the… read more.
A study of discontinuing natalizumab for multiple sclerosis patients testing positive for JC virus antibody found a higher relapse rate within 6 months than for patients continuing the… read more.
by Maria Dalby reporting on the presentation by Miriam Manook et al, Guy’s Hospital, London. Adequate training of transplant surgeons is essential for good clinical outcomes. Although surgical… read more.
A new study from researchers at Queen Mary, University of London shows how a particular virus tricks the immune system into triggering inflammation and nerve cell damage in… read more.
by Bruce Sylvester – Stroke patients with a history of stroke or diabetes who received clot-busting drugs post-stroke have achieved better outcomes than those who did not receive… read more.
Advertisment